Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07PZQ
|
|||
| Former ID |
DIB020239
|
|||
| Drug Name |
L-serine-O-phosphate
|
|||
| Synonyms |
Phosphoserine; O-phospho-L-serine; Dexfosfoserine; phosphoserine; 407-41-0; L-O-Phosphoserine; Fosforina; O-Phosphoserine; L-SOP; L-Phosphoserine; PHOSPHONOSERINE; 3-phosphoserine; L-Serine O-phosphate; Dexfosfoserine [INN]; Phosphatidalserine; 3-O-Phosphoserine; H-Ser(PO3H2)-OH; O-phosphono-L-serine; serine, O-phosphono-; (+)-L-Serine dihydrogen phosphate (ester); L-Seryl phosphate; UNII-VI4F0K069V; L-3-Phosphoserine; L-O-Serine phosphate; L-Serinephosphoric acid; H-Ser(PO)-OH; L-2-amino-3-hydroxypropanoic acid 3-phosphate; LSOP; Phosphonoserine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C3H8NO6P
|
|||
| Canonical SMILES |
C(C(C(=O)O)N)OP(=O)(O)O
|
|||
| InChI |
1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1
|
|||
| InChIKey |
BZQFBWGGLXLEPQ-REOHCLBHSA-N
|
|||
| CAS Number |
CAS 407-41-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
4251, 825453, 841619, 7890432, 7980684, 8145118, 8192381, 11113423, 15340053, 17405445, 24277998, 26751660, 29203220, 43125355, 46505297, 46517825, 47440569, 50068315, 50104360, 50104361, 53777992, 56435316, 56435317, 56435318, 57317099, 57410966, 79764880, 85165191, 85240002, 87574914, 90341677, 91701988, 92298672, 92304275, 103204663, 103843432, 104343198, 117626830, 121361478, 121362097, 124750074, 124886904, 126523129, 127591104, 131331990, 132521938, 135028622, 135651511, 135676490, 136023595
|
|||
| ChEBI ID |
CHEBI:15811
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1411). | |||
| REF 3 | Serine-O-phosphate has affinity for type IV, but not type I, metabotropic glutamate receptor. Neuroreport. 1993 Sep;4(9):1099-101. | |||
| REF 4 | Cloning, distribution and functional expression of the human mGlu6 metabotropic glutamate receptor. Neuropharmacology. 1997 Feb;36(2):145-52. | |||
| REF 5 | Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes. Naunyn Schmiedebergs Arch Pharmacol. 2000 Dec;362(6):546-54. | |||
| REF 6 | Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8. Brain Res Mol Brain Res. 1999 Apr 20;67(2):201-10. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.